A detailed history of Planned Solutions, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Planned Solutions, Inc. holds 34 shares of EXAS stock, worth $2,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Holding current value
$2,019
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$42.43 - $70.83 $1,442 - $2,408
34 New
34 $2,000
Q4 2023

Jan 17, 2024

BUY
$59.06 - $75.72 $2,008 - $2,574
34 New
34 $2,000
Q1 2021

Apr 29, 2021

SELL
$116.57 - $155.01 $3,963 - $5,270
-34 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$72.92 - $102.01 $2,479 - $3,468
34 New
34 $3,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Planned Solutions, Inc. Portfolio

Follow Planned Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planned Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planned Solutions, Inc. with notifications on news.